"RIV/00216208:11140/14:10282606!RIV15-MSM-11140___" . . "CZ - \u010Cesk\u00E1 republika" . . . . "I" . . "Z\u00E1sady antiemetick\u00E9 l\u00E9\u010Dby v pneumoonkologii"@cs . "Antiemetics News" . "[965715156104]" . "pneumooncology; aprepitant; emetogenity; CINV; chemotherapy; emesis"@en . . . . . "Chemotherapy induced nausea and vomiting (CINV) is one of the most troubling side effects of chemotherapy from the patient point of view. Without antiemetic prophylaxis, CINV is present in more than 70% of patients. The article is bringing the overview of chemotherapeutic agents and other preparations used in pneumooncology, with the stated grade of emetogenity. Than it states the recommendations for CINV prevention and treatment arising from recent NCCN, ASCO, MASCC guidelines. Combination of aprepitant, setron plus corticosteroid is recommended for highly emetogenic chemotherapy."@en . "4"^^ . . "Kr\u00E1korov\u00E1, Gabriela" . . "Z\u00E1sady antiemetick\u00E9 l\u00E9\u010Dby v pneumoonkologii"@cs . "Chemoterapi\u00ED indukovan\u00E1 nauzea a zvracen\u00ED (CINV) je z pohledu pacienta jedn\u00EDm z nejv\u00EDce obt\u011B\u017Euj\u00EDc\u00EDch ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F chemotrapie. Bez antiemetick\u00E9 profylaxe je CINV p\u0159\u00EDtomno u v\u00EDce ne\u017E 70% nemocn\u00FDch. \u010Cl\u00E1nek p\u0159in\u00E1\u0161\u00ED p\u0159ehled cytostatik a dal\u0161\u00EDch prepar\u00E1t\u016F pou\u017E\u00EDvan\u00FDch v pneumoonkologii, s uveden\u00EDm stupn\u011B jejich emetogenity. D\u00E1le uv\u00E1d\u00ED doporu\u010Den\u00ED pro prevenci a l\u00E9\u010Dbu CINV, vypl\u00FDvaj\u00EDc\u00ED z recentn\u00EDch guidelines NCCN, ASCO a MASCC. Pro vysoce emetogenn\u00ED chemoterapii je v prevenci CINV doporu\u010Dov\u00E1na kombinace aprepitantu, setronu a kortikosteroid\u016F." . "1804-8226" . "1"^^ . "1" . . . . . . "Chemoterapi\u00ED indukovan\u00E1 nauzea a zvracen\u00ED (CINV) je z pohledu pacienta jedn\u00EDm z nejv\u00EDce obt\u011B\u017Euj\u00EDc\u00EDch ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F chemotrapie. Bez antiemetick\u00E9 profylaxe je CINV p\u0159\u00EDtomno u v\u00EDce ne\u017E 70% nemocn\u00FDch. \u010Cl\u00E1nek p\u0159in\u00E1\u0161\u00ED p\u0159ehled cytostatik a dal\u0161\u00EDch prepar\u00E1t\u016F pou\u017E\u00EDvan\u00FDch v pneumoonkologii, s uveden\u00EDm stupn\u011B jejich emetogenity. D\u00E1le uv\u00E1d\u00ED doporu\u010Den\u00ED pro prevenci a l\u00E9\u010Dbu CINV, vypl\u00FDvaj\u00EDc\u00ED z recentn\u00EDch guidelines NCCN, ASCO a MASCC. Pro vysoce emetogenn\u00ED chemoterapii je v prevenci CINV doporu\u010Dov\u00E1na kombinace aprepitantu, setronu a kortikosteroid\u016F."@cs . "57064" . "Z\u00E1sady antiemetick\u00E9 l\u00E9\u010Dby v pneumoonkologii" . "1"^^ . "The principles of antiemetic treatment in pneumooncology"@en . "11140" . . "The principles of antiemetic treatment in pneumooncology"@en . "RIV/00216208:11140/14:10282606" . "4" . "Z\u00E1sady antiemetick\u00E9 l\u00E9\u010Dby v pneumoonkologii" .